A collaborative study by the Tufts Center for the Study of Drug Development and CRIO identifies protocol interpretation and ...
In a recent video interview with Applied Clinical Trials, Mwango Kashoki, MD, MPH, senior vice president and global head of ...
In today's ACT Brief, we examine Thermo Fisher's expanded real-world data access through HealthVerity, how FHIR-based ...
In today's ACT Brief, we explore industry perspectives on operational and methodological shifts defining 2026, how agentic AI will augment clinical trial roles over the next two years, and Roche's ...
In a recent video interview with Applied Clinical Trials, Nick Frenzer, general manager of site solutions at Veeva Systems, discussed why eSource has remained c ...
The HealthVerity agreement is the latest in a series of data partnerships through which Thermo Fisher has been expanding its ...
In today's ACT Brief, we explore why clinical trial diversity requires protocol redesign from the outset, the highest-impact ...
In this video interview, Cheryl Kole, vice president of solution strategy and commercialization at Almac Clinical ...
In today's ACT Brief, we explore how user-friendly technology reduces errors and site workarounds, strategic approaches to ...
In this Q&A, Krishna Cheriath, VP and head of clinical research digital data and AI at Thermo Fisher Scientific, examines how ...
Real-world data is increasingly used to optimize trial design, reduce recruitment burden, and support regulatory decisions, but adoption remains uneven due to challenges around data quality, ...
In a recent video interview with Applied Clinical Trials, Krishna Cheriath, vice president and head of clinical research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results